Nanobiotix (NBTX) Total Non-Current Liabilities (2019 - 2025)

Historic Total Non-Current Liabilities for Nanobiotix (NBTX) over the last 7 years, with Q2 2025 value amounting to $57.8 million.

  • Nanobiotix's Total Non-Current Liabilities rose 338.98% to $57.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $57.8 million, marking a year-over-year increase of 338.98%. This contributed to the annual value of $80.3 million for FY2024, which is 6184.01% up from last year.
  • As of Q2 2025, Nanobiotix's Total Non-Current Liabilities stood at $57.8 million, which was up 338.98% from $79.3 million recorded in Q4 2024.
  • In the past 5 years, Nanobiotix's Total Non-Current Liabilities ranged from a high of $79.3 million in Q4 2024 and a low of $38.7 million during Q2 2022
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $51.7 million (2021), whereas its average is $54.1 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 2772.77% in 2022, then skyrocketed by 6064.31% in 2024.
  • Nanobiotix's Total Non-Current Liabilities (Quarter) stood at $53.5 million in 2021, then fell by 6.83% to $49.9 million in 2022, then dropped by 1.04% to $49.3 million in 2023, then surged by 60.64% to $79.3 million in 2024, then fell by 27.05% to $57.8 million in 2025.
  • Its Total Non-Current Liabilities stands at $57.8 million for Q2 2025, versus $79.3 million for Q4 2024 and $55.9 million for Q2 2024.